ACCUZIDE

10MG/12,5MG TBL FLM 100

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 26.07.2021
Interruption of marketing 22.07.2021 LP se samostatně registrovanými léčivými látkami Manufacturing reasons 4.8.2021
Resumption of marketing 25.02.2020
Interruption of marketing 14.11.2019 Lék není nahraditelný Manufacturing reasons 31.03.2020
Resumption of marketing 16.08.2019
Interruption of marketing 23.05.2019 Lék není nahraditelný Manufacturing reasons první polovina srpna 2019
Resumption of marketing 07.05.2019
Interruption of marketing 07.12.2018 LP se samostatně registrovanými léčivými látkami Capacity/distribution reasons 29.04.2019
Resumption of marketing 10.07.2018
Interruption of marketing 23.05.2018 LP se samostatně registrovanými léčivými látkami
Resumption of marketing 05.12.2017
Interruption of marketing 03.10.2017 0127863, 0016608, 0016613
Resumption of marketing 25.07.2016
Interruption of marketing 05.05.2016 0016608, 0016613, 0076708
Resumption of marketing 27.07.2015
Interruption of marketing 07.04.2015 0127863, 0016608, 0016613
Resumption of marketing 07.04.2015
Interruption of marketing 18.03.2015 0127863, 0016608, 0016613
Resumption of marketing 02.02.2015
Interruption of marketing 08.12.2014 0127863, 0016608, 0016613
Resumption of marketing 09.10.2014
Interruption of marketing 24.09.2014 0127863, 0016608, 0016613, 0076708

All reports are available in the Overview.

Back to list